Production (Stage)
Zymeworks Inc.
ZYME
$11.54
$0.060.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 85.05% | 0.38% | -86.52% | -85.99% | -88.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 85.05% | 0.38% | -86.52% | -85.99% | -88.69% |
| Cost of Revenue | 6.28% | -5.25% | -27.54% | -31.38% | -31.99% |
| Gross Profit | 43.61% | 11.66% | -121.05% | -120.96% | -131.28% |
| SG&A Expenses | -9.51% | -12.69% | -31.16% | -26.70% | -13.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.79% | -7.71% | -28.77% | -29.83% | -26.46% |
| Operating Income | 27.75% | 12.19% | -159.59% | -164.53% | -185.15% |
| Income Before Tax | 16.18% | 2.21% | -153.55% | -157.96% | -169.12% |
| Income Tax Expenses | 445.46% | 1,171.13% | -128.72% | -124.74% | -115.24% |
| Earnings from Continuing Operations | 9.76% | -3.39% | -155.38% | -160.46% | -172.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.76% | -3.39% | -155.38% | -160.46% | -172.98% |
| EBIT | 27.75% | 12.19% | -159.59% | -164.53% | -185.15% |
| EBITDA | 29.57% | 12.00% | -153.20% | -157.25% | -176.55% |
| EPS Basic | 15.97% | 6.95% | -148.23% | -154.13% | -168.88% |
| Normalized Basic EPS | 34.61% | 23.87% | -140.37% | -144.86% | -165.70% |
| EPS Diluted | 16.09% | 7.23% | -148.57% | -154.57% | -169.40% |
| Normalized Diluted EPS | 34.64% | 23.90% | -140.41% | -144.91% | -165.79% |
| Average Basic Shares Outstanding | 6.13% | 10.16% | 10.50% | 10.11% | 7.07% |
| Average Diluted Shares Outstanding | 6.16% | 10.20% | 10.50% | 10.10% | 7.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |